Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2
Islets · 2014-01-14 · 6 (1) · e28095
DOI: 10.4161/isl.28095 ↗At a glance
Journal article in Islets, published online on 2014-02-18. Written by Thomas M Reinbothe and 4 co-authors. Institution: a Department of Clinical Sciences; Lund University Diabetes Centre; Malmö, Sweden. Major MEDLINE topics: Optogenetics. Cited 65 times so far (Crossref); 28 references. The full text is freely available in PubMed Central.
Abstract (original language)
Insulin is secreted from the pancreatic β-cells in response to elevated glucose. In intact islets the capacity for insulin release is determined by a complex interplay between different cell types. This has made it difficult to specifically assess the role of β-cell defects to the insulin secretory impairment in type 2 diabetes. Here we describe a new approach, based on optogenetics, that enables specific investigation of β-cells in intact islets. We used transgenic mice expressing the light-sensitive cation channel Channelrhodopsin-2 (ChR2) under control of the insulin promoter. Glucose tolerance in vivo was assessed using intraperitoneal glucose tolerance tests, and glucose-induced insulin release was measured from static batch incubations. ChR2 localization was determined by fluorescence confocal microscopy. The effect of ChR2 stimulation with blue LED light was assessed using Ca(2+) imaging and static islet incubations. Light stimulation of islets from transgenic ChR2 mice triggered prompt increases in intracellular Ca(2+). Moreover, light stimulation enhanced insulin secretion in batch-incubated islets at low and intermediate but not at high glucose concentrations. Glucagon release was not affected. Beta-cells from mice rendered diabetic on a high-fat diet exhibited a 3.5-fold increase in light-induced Ca(2+) influx compared with mice on a control diet. Furthermore, light enhanced insulin release also at high glucose in these mice, suggesting that high-fat feeding leads to a compensatory potentiation of the Ca(2+) response in β-cells. The results demonstrate the usefulness and versatility of optogenetics for studying mechanisms of perturbed hormone secretion in diabetes with high time-resolution and cell-specificity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- a Department of Clinical Sciences; Lund University Diabetes Centre; Malmö, Sweden.
Cite
APA
Reinbothe, T. M., Safi, F., Axelsson, A. S., Mollet, I. G., & Rosengren, A. H. (2014). Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2. Islets, 6(1), e28095. https://doi.org/10.4161/isl.28095
Vancouver
Reinbothe TM, Safi F, Axelsson AS, Mollet IG, Rosengren AH. Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2. Islets. 2014;6(1):e28095. doi:10.4161/isl.28095
BibTeX
@article{Reinbothe2014,
author = {Reinbothe, Thomas M and Safi, Fatemeh and Axelsson, Annika S and Mollet, Inês G and Rosengren, Anders H},
title = {Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2},
journal = {Islets},
year = {2014},
volume = {6},
number = {1},
pages = {e28095},
doi = {10.4161/isl.28095}
}
EUVIMED